Physician profile
Mark V Hendricks
NPI 1306827639
$11,291.93
in general payments reported to CMS, 2019-2025
39 companies · $1,502 in 2025
The $1,502 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,138 · 2020: $1,998 · 2021: $977 · 2022: $865 · 2023: $892 · 2024: $3,920 · 2025: $1,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,542 · Education: $2,534 · Travel and Lodging: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,541.92 |
| Education | $2,534.00 |
| Travel and Lodging | $237.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,855.59 | 2024 | |
| Insmed, INC. | $1,317.42 | 2019-2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $1,250.87 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $825.80 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Veran Medical Technologies, INC. | $732.45 | 2019-2020 | |
| Inspire Medical Systems, INC. | $714.67 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $477.30 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Genzyme Corporation | $350.20 | 2020-2025 | |
| Mylan Specialty L.P. | $231.02 | 2019-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $216.88 | 2019-2024 | Opsumit, Uptravi |
| Amgen INC. | $178.43 | 2022-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $166.81 | 2022-2025 | Zerbaxa, Dificid, Recarbrio |
| Bayer Healthcare Pharmaceuticals INC. | $158.46 | 2020-2025 | |
| Grifols USA, LLC | $158.37 | 2022-2025 | Prolastin-C Liquid |
| Baxter Healthcare | $156.59 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.